We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
-2.81%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$25.2B
AUM Growth
+$145M
(+0.58%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
11.42%
Holding
1,496
New
423
Increased
299
Reduced
316
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$278M |
| 2 |
Analog Devices
ADI
|
+$181M |
| 3 |
Target
TGT
|
+$172M |
| 4 |
Visa
V
|
+$150M |
| 5 |
Broadcom
AVGO
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$454M |
| 2 |
Micron Technology
MU
|
+$168M |
| 3 |
Suncor Energy
SU
|
+$146M |
| 4 |
Cheniere Energy
LNG
|
+$129M |
| 5 |
Amazon
AMZN
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.22% |
| 2 | Technology | 16.94% |
| 3 | Consumer Discretionary | 10.54% |
| 4 | Industrials | 7.2% |
| 5 | Energy | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Quanterix
QTRX
$177M
| $6.28M | 0.02% |
215,000
+30,400
| +16% | +$929K |
|
627
Theravance Biopharma
TBPH
$876M
| $6.27M | 0.02% |
656,100
+511,000
| +352% | +$5.01M |
|
628
Southwest Gas
SWX
$6.56B
| $6.26M | 0.02% |
80,000
+10,000
| +14% | +$701K |
|
629
Syndax Pharmaceuticals
SNDX
$1.77B
| $6.26M | 0.02% |
360,000
+6,900
| +2% | +$116K |
|
630
Acadia Healthcare
ACHC
$3B
| $6.25M | 0.02% |
95,319
-86,998
| -48% | -$5.05M |
|
|
JMIA
631
Jumia Technologies
JMIA
$727M
| $6.21M | 0.02% |
647,800
+342,017
| +112% | +$3.05M |
|
632
Cleveland-Cliffs
CLF
$7.22B
| $6.15M | 0.02% |
+190,869
| New | +$4.35M |
|
633
Globus Medical
GMED
$10.9B
| $6.1M | 0.02% |
82,650
-177,800
| -68% | -$12.4M |
|
634
Alibaba
BABA
$308B
| $6.02M | 0.02% |
55,362
+13,962
| +34% | +$1.61M |
|
|
CMRC
635
Commerce.com Inc Series 1
CMRC
$281M
| $5.96M | 0.02% |
272,100
-25,200
| -8% | -$676K |
|
636
PUT
Mercado Libre
MELI
$97.5B
| $5.95M | 0.02% |
+5,000
| New | +$5.44M |
|
637
Gulfport Energy Corp
GPOR
$2.81B
| $5.92M | 0.02% |
65,929
+32,151
| +95% | +$2.33M |
|
638
Gildan
GIL
$10.8B
| $5.91M | 0.02% |
157,659
+48,508
| +44% | +$1.9M |
|
639
Pilgrim's Pride
PPC
$6.33B
| $5.9M | 0.02% |
+235,100
| New | +$6.1M |
|
640
nVent Electric
NVT
$26.2B
| $5.89M | 0.02% |
169,231
+110,293
| +187% | +$3.86M |
|
641
Century Therapeutics
IPSC
$353M
| $5.88M | 0.02% |
467,390
+56,590
| +14% | +$750K |
|
|
PARA
642
PUT
DELISTED
Paramount Global Class B
PARA
| $5.86M | 0.02% |
+155,000
| New | +$5.28M |
|
643
Halliburton
HAL
$26.6B
| $5.85M | 0.02% |
154,454
+117,302
| +316% | +$3.79M |
|
|
ORIO
644
Orion Digital Corp
ORIO
$15.6M
| $5.84M | 0.02% |
669,384
-29,140
| -4% | -$213K |
|
|
SPWR
645
DELISTED
SunPower Corporation Common Stock
SPWR
| $5.84M | 0.02% |
+271,801
| New | +$4.99M |
|
646
MasTec
MTZ
$21.4B
| $5.84M | 0.02% |
67,000
+53,200
| +386% | +$4.65M |
|
|
HARP
647
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $5.81M | 0.02% |
116,832
+51,832
| +80% | +$2.69M |
|
648
PUT
PayPal
PYPL
$49.6B
| $5.78M | 0.02% |
+50,000
| New | +$6.65M |
|
649
Children's Place
PLCE
$58M
| $5.72M | 0.02% |
116,094
+96,294
| +486% | +$6.13M |
|
650
Ambarella
AMBA
$3.59B
| $5.72M | 0.02% |
54,500
-59,820
| -52% | -$7.62M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Point72 Asset Management held 1,496 positions worth $25.2B, up 0.58% from $25B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Point72 Asset Management deployed $1.25B of net new capital in Q1 2022, opening 423 new positions and adding to 299 existing holdings. Its largest new stake was Target: 794,997 shares worth $169M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Micron Technology, an estimated $168M trimmed.
- Point72 Asset Management's largest Q1 2022 buy was Target: 794,997 shares worth $169M.
- Point72 Asset Management added most to Merck in Q1 2022, an estimated $278M increase.
- Point72 Asset Management's biggest Q1 2022 reduction was Micron Technology, cutting an estimated $168M.
- Point72 Asset Management fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $454M.
- Point72 Asset Management's ten largest holdings make up 11% of its $25.2B portfolio in Q1 2022.
- Point72 Asset Management opened 423 new positions and closed 358 in Q1 2022.
- Point72 Asset Management's portfolio value rose 0.58% quarter-over-quarter to $25.2B.
Based on Point72 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.